Piramal Enterprises launch portable diagnostic device

The device that tests for 20 clinical parameters has been received well with 387 instruments being sold within just 45 days of the test marketing launch

piramal-enterprises

Piramal Enterprises' diagnostic division recently announced the launch of "QDx Instacheck" -Right-here-Right-now. It is touted to be a first-of-its-kind portable diagnostic device that is specifically designed to perform 20 clinical parameters and deliver quantitative results within 3 - 15 minutes. It covers wide therapeutic areas including cardiovascular disease, hormonal imbalance, emergency care, diabetes, oncology, infections, pregnancy and infertility management.

This portable and affordable device is considered to deliver quantitative test results with high accuracy. The device is virtually maintenance free and can be operated very easily with minimal training requirements. QDx Instacheck is particularly useful for doctors' clinics, emergency care units (such as ICU, CCU), hospitals, pathological labs, IVF centres, ambulance services, pharmaceutical companies and NGOs engaged in healthcare services.

Commenting on the launch Mr. Vijay Shah, Executive Director and Chief Operating Officer, Piramal Enterprises said, "It is our endeavour to empower the medical community such as gynaecologists, cardiologists, diabetologists, general physicians, pathological labs to perform critical tests Right-here-Right-now with minimum investment and lowest operating expenses and finally making treatment decisions faster. The launch of QDx Instacheck is in line with our division's vision of bringing affordable instant diagnostic solution through our point-of-care product range. This 1.3 kg portable device is the first-of-its-kind revolutionary instant diagnostic device in the Indian market that is poised to change traditional diagnostic methods to instant diagnosis."

QDx Instacheck has been commercially test marketed from January to March 2013 across various parts of India through our field force and over 250 authorised distributors. The formal launch of the product is scheduled in April 2013. A record of 387 instruments was sold in just 45 days from test marketing launch.

2 Comment Comment 1 - 1 of 1
comment

Jose 10 April 2013 at 06:52 AM

Oui, K ,dans l temps,j ai connu un photographe qui mais, ici, esyases donc les douches e9cossaises: c est souverain! Et puis au lieu de stresser, arreates donc ton char, prends ton jet(ame8nes-nous ton innnnnimitable TART AL POM -ave9 lassen-) avant de repartir en navette spaciale pour nous envoyer encore d autres infos side9rales.-Babs-:pour les ceux qui savent.

Reply

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

BusinessWire India.com - Pharmaceutical

Bwi-logo

Replicor discloses achievement of 1 year functional control of HBV and

Friday, 21 Apr 2017   |   Replicor Inc.

Business Wire India Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

BusinessWire India.com - Medical Devices

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email

X